New Message from President
Meeting Material for the Briefing on the Second Quater FY2017 Financial Results
Consolidated Financial Results for the Second Quarter of Fiscal Year 2017
Seikagaku Announces the Results of SI-6603 Phase III Clinical Trials in the U.S., Indicated for Treatment of Lumbar Disc Herniation
Seikagaku will announce the financial results for the Second Quarter of the Fiscal Year ending March 31, 2018 at 16:00 on November 7, 2017.